Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 1.51 trillion as of February 27, 2026. Its market cap has increased by 197.30% in one year.

Market Cap

1.51T

Enterprise Value

1.48T

Revenue

1.96B

Ranking

n/a

PE Ratio

n/a

Stock Price

15,680.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 1.51T, an increase of 3,070.61%. That is a compound annual growth rate of 16.21%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	1.51T	215.81%
Dec 30, 2025	476.82B	-15.13%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1.04T	-4.44%
Dec 29, 2022	1.09T	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	81.75T
Celltrion	52.97T
ALTEOGEN	21.55T
Sam Chun Dang Pharm.	17.61T
L&C BIO Co.,LTD	2.41T
Daewoong Pharmaceutical	2.13T
Chabiotech	1.97T
Oscotec	1.96T

Market Cap Rankings